Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GWPH

GW Pharmaceuticals (GWPH) Stock Price, News & Analysis

GW Pharmaceuticals logo

About GW Pharmaceuticals Stock (NASDAQ:GWPH)

Advanced Chart

Key Stats

Today's Range
$218.96
$218.96
50-Day Range
$216.90
$219.28
52-Week Range
$87.07
$219.57
Volume
N/A
Average Volume
899,771 shs
Market Capitalization
$6.86 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive GWPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for GW Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

GWPH Stock News Headlines

Musk Warns. Trump Acts. Your Retirement May Depend on It
With Donald Trump back in the White House, many believe an economic revival could be underway — but it also brings new risks for retirement savers. Traditional 401(k)s and IRAs may leave investors more exposed than they realize. That’s why a Trump-backed IRS strategy is gaining attention. It allows everyday Americans to reposition their retirement savings into real assets like gold and silver — offering both protection and potential upside. A new 2025 Wealth Protection Guide explains exactly how it works.tc pixel
GWPRF Historical Data
George Washington University
China Approves 106 GW of New Coal-Fired Capacity
Why Nasdaq-Traded Marijuana Stocks Remain Undervalued
GW Pharmaceuticals PLC (GWPRF)
See More Headlines

GWPH Stock Analysis - Frequently Asked Questions

GW Pharmaceuticals plc (NASDAQ:GWPH) released its earnings results on Tuesday, November, 3rd. The biopharmaceutical company reported ($0.36) earnings per share for the quarter, beating the consensus estimate of ($0.63) by $0.27. GW Pharmaceuticals's revenue was up 50.7% compared to the same quarter last year.

Based on aggregate information from My MarketBeat watchlists, some other companies that GW Pharmaceuticals investors own include NVIDIA (NVDA), Canopy Growth (CGC), Meta Platforms (META), Tesla (TSLA), Netflix (NFLX), Advanced Micro Devices (AMD) and Alibaba Group (BABA).

Company Calendar

Last Earnings
11/03/2020
Today
9/07/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical Preparations
Sub-Industry
N/A
Current Symbol
NASDAQ:GWPH
CIK
1351288
Fax
N/A
Employees
1,161
Year Founded
1998

Profitability

EPS (Trailing Twelve Months)
($0.24)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$9.02 million
Net Margins
-11.05%
Pretax Margin
N/A
Return on Equity
-7.46%
Return on Assets
-6.13%

Debt

Debt-to-Equity Ratio
0.01
Current Ratio
5.13
Quick Ratio
4.31

Sales & Book Value

Annual Sales
$311.33 million
Price / Sales
22.05
Cash Flow
$0.01 per share
Price / Cash Flow
18,588.22
Book Value
$23.48 per share
Price / Book
9.33

Miscellaneous

Outstanding Shares
31,349,000
Free Float
N/A
Market Cap
$6.86 billion
Optionable
Optionable
Beta
2.15

Social Links

Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

This page (NASDAQ:GWPH) was last updated on 9/7/2025 by MarketBeat.com Staff
From Our Partners